SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 49.41 |
| Enterprise Value ($M) | -83.48 |
| Book Value ($M) | 133.03 |
| Book Value / Share | 12.47 |
| Price / Book | 0.37 |
| NCAV ($M) | 121.19 |
| NCAV / Share | 11.36 |
| Price / NCAV | 0.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.26 |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.96 |
| Current Ratio | 19.96 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 138.89 |
| Assets | 150.73 |
| Liabilities | 17.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.44 |
| Operating Income | -40.87 |
| Net Income | -35.13 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -49.06 |
| Cash from Investing | 0.36 |
| Cash from Financing | 175.85 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Biotechnology Value Fund L P | 9.99 | 7.37 | |
| 13G | Affinity Asset Advisors, LLC | 5.30 | ||
| 13G/A | Allostery Investments LP | 0.50 | -28.64 | |
| 13G | Orbimed Advisors Llc | 9.90 | ||
| 13G/A | Crutcher Patrick J | 5.60 | 395.68 | |
| 13G | Ikarian Capital, LLC | 10.02 | ||
| 13G | Ra Capital Management, L.p. | 9.99 | ||
| 13G | Emerald Bioventures, LLC | 5.60 | ||
| 13G | Deep Track Capital, LP | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,449 | 71,408 | 11.83 | |
| 8,566 | 25,514 | 33.57 | |
| 31,220 | 259,515 | 12.03 | |
| 30,165 | 91,467 | 32.98 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATNF – 180 Life Sciences Corp. | ATOS – Atossa Therapeutics, Inc. |
| ATYR – aTyr Pharma, Inc. | AYTU – Aytu BioPharma, Inc. |
| BCDA – BioCardia, Inc. |
Financial data and stock pages provided by
Fintel.io